Skip to content
Go To Homepage
  • Products
    • Oncology
    • Prenatal
  • Our Technology
    • Technology
    • Publications
  • Careers
    • Working with Us
    • Open Positions
  • News & Media
    • Press Releases
    • Media Coverage
    • Events
    • Social Media
  • About Us
    • Mission, Vision, Values
    • Leadership & Board
    • Company Milestones
  • Contact
abstract pattern of dots and lines

News & Media

Media Coverage

April 13, 2020

New Coronavirus Protocol To Unlock A Million Daily Tests

Read

Media Coverage

April 13, 2020

A new approach to testing for COVID-19 could be just on the horizon.

Read

Media Coverage

April 11, 2020

Sanger sequencing-based COVID-19 test to be developed by BillionToOne

Read

Media Coverage

April 11, 2020

BillionToOne Goes Beyond qPCR with Sanger-Based COVID-19 Test

Read

Media Coverage

April 11, 2020

A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing

Read

Media Coverage

April 11, 2020

New COVID19 Test Unlocking One Million Daily Tests

Read

Follow Us

  • LinkedIn
  • Twitter

See Recent Social Posts

Social Posts

Get more news sent directly to your inbox.

Newsletter(Required)
This field is for validation purposes and should be left unchanged.
Go To Homepage

We are ONE team, working
toward ONE goal – to detect
disease ONE molecule at a time.

CAP Accredited College of American Pathologists

  • What We Offer
  • Our Technology
  • Publications
  • Products
  • Explore
  • News & Media
  • Press Releases
  • Media Coverage
  • Events
  • Social Media
  • About Us
  • Careers
  • Patient Portal
  • Contact
  • Contact Information
  • Privacy Policy
  • Notice of Privacy Practices
  • Accessibility Statement
  • TERMS OF USE

ACCREDITATIONS UNION CITY: CLIA: 05D2167800 | CAP: 8643216 | MD: 2999 | RI: LCO01527 | PA: 37021 | CA: 00353741 | DC: HFD-OS29

ACCREDITATIONS MENLO PARK: CA: 90008579  | CAP: 9568790

PATENT MARKINGS

© 2025 BillionToOne Inc.
All rights reserved.